WebJan 21, 2024 · Abbott. Jan 21, 2024, 09:00 ET. ABBOTT PARK, Ill., Jan. 21, 2024 /PRNewswire/ -- Abbott (NYSE: ABT ) today announced U.S. Food and Drug Administration (FDA) approval of the TactiCath™ Contact ... WebAug 4, 2024 · ABBOTT PARK, Ill., Aug. 4, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced first enrollments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation (PAF), a type of irregular heartbeat. The study will evaluate the performance of the investigational TactiFlex™ Ablation Catheter, …
TactiCath Ablation Catheter, SE Overview Abbott
WebJan 28, 2024 · Device: TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) TactiCath SE is indicated for use in cardiac electrophysiological mapping (stimulation and recording), and, when used in conjunction with a radiofrequency generator, for cardiac ablation of supraventricular arrhythmias in the right and left atrium, including ... WebNov 28, 2024 · This clinical investigation is intended to demonstrate the acute safety and effectiveness of ablation with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ (TactiCath SE) for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF). ... Abbott Medical Devices: ClinicalTrials.gov Identifier ... how to share profile on handshake
Abbott reports results from study of TactiCath SE for atrial …
WebPN-004 075 TactiCath™ Irrigated Ablation Catheter (75mm curve - 7F, 115cm, 2-5-2mm spacing) TACTICATH ™ QUARTZ Contact Force Ablation Catheter Open-irrigated 7 F ablation catheter with 75 or 65 mm steerable curve TACTICATH™ QUARTZ ABLATION CATHETER FEATURES AND REQUIREMENT The main features of this unique ablation … WebNeuromodulation. Learn more about the patents we hold for our products. Products will be listed alphabetically. Additional patents may be pending. Devices may not be approved in all geographies. Products listed here may not be approved in all countries. Listing of the patent information does not mean to confer approval status. WebAug 5, 2024 · By GlobalData. Named TactiFlex Ablation Catheter, Sensor Enabled (SE), the device will be tested in patients who had no adequate response to medication for their atrial fibrillation (AFib) symptoms. The study will involve 355 patients at several sites globally. Participants will undergo an ablation procedure, using Abbott’s new device. how to share profile in upwork